ImportRefusal LogoImportRefusal

Roche Phils

⚠️ Moderate Risk

FEI: 3002923769 • Makati, National Capital Region • PHILIPPINES

FEI

FEI Number

3002923769

📍

Location

Makati, National Capital Region

🇵🇭
🏢

Address

2252 Chino Roces Avenue, , Makati, National Capital Region, Philippines

Moderate Risk

FDA Import Risk Assessment

32.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
4
Unique Violations
8/12/2009
Latest Refusal
5/11/2005
Earliest Refusal

Score Breakdown

Violation Severity
55.7×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
11.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/12/2009
65VCE15DIAZEPAM (SEDATIVE)
118NOT LISTED
San Francisco District Office (SAN-DO)
7/16/2009
60RBH18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC)
75UNAPPROVED
San Francisco District Office (SAN-DO)
8/26/2005
75NBWSYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER
118NOT LISTED
341REGISTERED
508NO 510(K)
San Francisco District Office (SAN-DO)
5/11/2005
62MDY99ANTI-PRURITIC N.E.C.
118NOT LISTED
San Francisco District Office (SAN-DO)
5/11/2005
62GDY49NAPROXEN (ANTI-INFLAMMATORY)
118NOT LISTED
San Francisco District Office (SAN-DO)

Frequently Asked Questions

What is Roche Phils's FDA import refusal history?

Roche Phils (FEI: 3002923769) has 5 FDA import refusal record(s) in our database, spanning from 5/11/2005 to 8/12/2009.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Roche Phils's FEI number is 3002923769.

What types of violations has Roche Phils received?

Roche Phils has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Roche Phils come from?

All FDA import refusal data for Roche Phils is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.